• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARIAD Pharmaceuticals Inc

+ Add to Watchlist


4.740 EUR 0.039 0.82%

As of 13:55:54 ET on 08/29/2014.

Snapshot for ARIAD Pharmaceuticals Inc (APS)

Open: 4.675 Day's Range: 4.585 - 4.812 Volume: 2,293
Previous Close: 4.779 52wk Range: 1.572 - 16.921 1-Yr Rtn: -66.69%

Stock Chart for APS

No chart data available.
  • APS:GR 4.740
  • 1D
  • 1M
  • 1Y
Interactive APS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.1430
Est. PEG Ratio -
Market Cap (M EUR) 886.43
Shares Outstanding (M) 187.01
30 Day Average Volume 11,269
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for APS

ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.

Harvey J BergerChairman/President/CEOTimothy P ClacksonChief Scientific Ofcr/Pres:R&D
Edward M FitzgeraldExec VP/CFO/TreasurerMartin J Duvall "Marty"Exec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for APS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil